Radioactive drug combo aims to zap rare gut tumors
NCT ID NCT04086485
Summary
This study is testing whether combining two drugs, Lutathera and Olaparib, can shrink rare neuroendocrine tumors in the digestive system or pancreas that cannot be removed by surgery. About 56 adults will receive Lutathera through an IV every 8 weeks and take Olaparib pills twice daily. The main goals are to find a safe dose and see if the treatment makes tumors get smaller.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.